Management of sciatica through enema and oral intake medicated oil.

Recruiting

• Conditions: Other specified acquired deformities of musculoskeletal system,

• Registration Number: CTRI/2019/02/017470
• Lead Sponsor: Rishikul campus

Brief Summary

Trial is going on..

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-02
• Last Update Posted: 2020-01-27

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Daignosed cases of gridhrasi(lumbosacral radiculopathy) Patient daiagnosed of lumbago based upon investigation History of lumbosal sprain/strain/ lumbago for more than six months.

Exclusion Criteria

Uncontrolled diabetes mellitus Uncontrolled T.B.of spine & hip joint Uncontrolled hypertention Malignancy of spine or other or organs Fracture related to spine Cardiac disease(IHD, CAD, MI etc) Anaemic(Hb% less than 7.00 mg/dl) Pregnancy Age group less than 20 years and greater than 60 years Refferred low backache from pelvis, abdomen or thoracic disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group.	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Moderately improved-51-75%	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Improved - 26-50%	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Complete remission-100%	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Unchanged - 0-25%	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Markedly improved-76-99%	Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%

Secondary Outcome Measures

Name	Time	Method
Excerbation in sign & symptoms	42 days

Trial Locations

Locations (1)

Rishikul campus UAU, haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Rishikul campus UAU, haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Anil kumar

Principal investigator

9926883253

aniltripathi0000@gmail.Com